» Articles » PMID: 35318656

Neuroradiological Basis of COVID-19 Olfactory Dysfunction: A Systematic Review and Meta-Analysis

Overview
Journal Laryngoscope
Date 2022 Mar 23
PMID 35318656
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Olfactory dysfunction (OD) is a common presenting symptom of COVID-19 infection. Radiological imaging of the olfactory structures in patients with COVID-19 and OD can potentially shed light on its pathogenesis, and guide clinicians in prognostication and intervention.

Methods: PubMed, Embase, Cochrane, SCOPUS were searched from inception to August 1, 2021. Three reviewers selected observational studies, case series, and case reports reporting radiological changes in the olfactory structures, detected on magnetic resonance imaging, computed tomography, or other imaging modalities, in patients aged ≥18 years with COVID-19 infection and OD, following preferred reporting items for systematic reviews and meta-analyses guidelines and a PROSPERO-registered protocol (CRD42021275211). We described the proportion of radiological outcomes, and used random-effects meta-analyses to pool the prevalence of olfactory cleft opacification, olfactory bulb signal abnormalities, and olfactory mucosa abnormalities in patients with and without COVID-19-associated OD.

Results: We included 7 case-control studies (N = 353), 11 case series (N = 154), and 12 case reports (N = 12). The pooled prevalence of olfactory cleft opacification in patients with COVID-19 infection and OD (63%, 95% CI = 0.38-0.82) was significantly higher than that in controls (4%, 95% CI = 0.01-0.13). Conversely, similar proportions of cases and controls demonstrated olfactory bulb signal abnormalities (88% and 94%) and olfactory mucosa abnormalities (2% and 0%). Descriptive analysis found that 55.6% and 43.5% of patients with COVID-19 infection and OD had morphological abnormalities of the olfactory bulb and olfactory nerve, respectively, while 60.0% had abnormal olfactory bulb volumes.

Conclusion: Our findings implicate a conductive mechanism of OD, localized to the olfactory cleft, in approximately half of the affected COVID-19 patients. Laryngoscope, 132:1260-1274, 2022.

Citing Articles

Long COVID-19-related and non-COVID-19 postviral olfactory dysfunction a comparative MRI study focusing on the olfactory cleft and bulbs.

Li Y, Liu M, Zhang R, Wang Y, Liu J Front Neurol. 2025; 15:1535699.

PMID: 39882367 PMC: 11774702. DOI: 10.3389/fneur.2024.1535699.


Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis.

Kitsios G, Blacka S, Jacobs J, Mirza T, Naqvi A, Gentry H BMJ Open. 2024; 14(3):e077869.

PMID: 38485476 PMC: 10941166. DOI: 10.1136/bmjopen-2023-077869.


A Comprehensive Review of COVID-19-Related Olfactory Deficiency: Unraveling Associations with Neurocognitive Disorders and Magnetic Resonance Imaging Findings.

Simonini L, Frijia F, Ait Ali L, Foffa I, Vecoli C, De Gori C Diagnostics (Basel). 2024; 14(4).

PMID: 38396398 PMC: 10888385. DOI: 10.3390/diagnostics14040359.


Altered structural connectivity in olfactory disfunction after mild COVID-19 using probabilistic tractography.

de Carvalho Bispo D, Brandao P, Pereira D, Maluf F, Dias B, Paranhos H Sci Rep. 2023; 13(1):12886.

PMID: 37558765 PMC: 10412532. DOI: 10.1038/s41598-023-40115-7.


Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis.

Afsahi A, Norbash A, Syed S, Sedaghat M, Afsahi G, Shahidi R J Neurol. 2023; 270(11):5131-5154.

PMID: 37535100 DOI: 10.1007/s00415-023-11914-9.


References
1.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

2.
Bowden J, Tierney J, Copas A, Burdett S . Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol. 2011; 11:41. PMC: 3102034. DOI: 10.1186/1471-2288-11-41. View

3.
Wrobel B, Leopold D . Smell and taste disorders. Facial Plast Surg Clin North Am. 2004; 12(4):459-68, vii. PMC: 7129740. DOI: 10.1016/j.fsc.2004.04.006. View

4.
Pang K, Chee J, Subramaniam S, Ng C . Frequency and Clinical Utility of Olfactory Dysfunction in COVID-19: a Systematic Review and Meta-analysis. Curr Allergy Asthma Rep. 2020; 20(12):76. PMC: 7552599. DOI: 10.1007/s11882-020-00972-y. View

5.
De Santis G . SARS-CoV-2: A new virus but a familiar inflammation brain pattern. Brain Behav Immun. 2020; 87:95-96. PMC: 7184990. DOI: 10.1016/j.bbi.2020.04.066. View